The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy

Gastroenterol Hepatol. 2020 Mar;43(3):136-137. doi: 10.1016/j.gastrohep.2019.04.007. Epub 2020 Jan 3.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Burkitt Lymphoma / complications
  • Burkitt Lymphoma / drug therapy
  • Common Variable Immunodeficiency / complications
  • Common Variable Immunodeficiency / therapy
  • Drug Therapy, Combination
  • Fatal Outcome
  • Focal Nodular Hyperplasia / complications
  • Focal Nodular Hyperplasia / surgery
  • Hepatitis E / complications
  • Hepatitis E / drug therapy*
  • Hepatitis E virus / drug effects
  • Hepatitis E virus / isolation & purification
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / therapeutic use
  • Kidney Transplantation
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / surgery
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Postoperative Complications / drug therapy*
  • RNA, Viral / blood
  • Recurrence
  • Ribavirin / therapeutic use*
  • Sofosbuvir / pharmacology
  • Sofosbuvir / therapeutic use*

Substances

  • Antiviral Agents
  • Immunoglobulins, Intravenous
  • RNA, Viral
  • Ribavirin
  • Sofosbuvir